心臓マーカー検査市場：製品、バイオマーカー、検査タイプ、疾患別-2024-2030年の世界予測

心臓マーカー検査市場規模は2023年に51億米ドルと推計され、2024年には55億米ドルに達し、CAGR 7.90％で2030年には86億9,000万米ドルに達すると予測されます。

心臓マーカー検査市場は、心血管疾患の診断と管理のためのバイオマーカーの使用を中心に展開される医療技術とサービスのスペクトラムで構成されます。心血管疾患の流行と効果的な診断の必要性により、心臓マーカーの採用が世界的に増加しています。心臓マーカーのポイントオブケア検査の台頭により、心血管疾患のスクリーニングが大幅に増加しました。心血管疾患の早期発見を奨励する取り組みも市場成長に寄与しています。しかし、心臓マーカー検査ソリューションの製品回収の発生は、市場の採用を制限する可能性があります。また、心臓市場検査の不正確さや限定された特異性に関連する懸念も、市場成長の課題となっています。さらに、検査技術の進歩と新たなバイオマーカーの統合が、市場に魅力的な機会を生み出しています。個別化医療に対する消費者の嗜好の高まりとテーラーメイドの心臓マーカー検査のイントロダクションは、今後数年間で大きな成長を示すことが期待されます。

製品心臓マーカー検査における診断機器の重要性

心臓マーカー検査における診断機器には、免疫測定装置、POC（Point of Care）機器、化学発光分析装置などが含まれ、心臓の状態に対応する心臓マーカーのモニタリングや測定に利用されます。診断機器は、心臓検査に不可欠なデータ評価を、高精度でタイムリーかつユーザーフレンドリーな方法で提供します。試薬・キットは、機器を適切に機能させ、心臓マーカー検査の手順を成功させるために使用される化学溶液です。試薬・キットは生体試料との反応に不可欠であり、様々な心臓疾患の心臓マーカーの検出に役立ちます。

バイオマーカー：心臓評価におけるトロポニンバイオマーカーの利用増加

N末端proBNP（NT-proBNP）やB型ナトリウム利尿ペプチド（BNP）などのナトリウム利尿ペプチドは、心不全の評価に不可欠であり、臨床医の心臓病管理に役立っています。クレアチンキナーゼ-MBアイソザイムであるCK-MBは、心筋梗塞周囲の検査に使用され、心疾患の診断に役立っています。高感度CRP（hs-CRP）検査は、心血管疾患や脳卒中のリスクを評価するための低悪性度炎症の同定に特に有利です。ミオグロビンもまた重要な心臓バイオマーカーであり、心筋損傷後の非常に早い時期（1～3時間）にピークを示すことから好まれ、主に心筋梗塞の早期発見に有益です。トロポニン検査は、その優れた感度と特異性により、現在、急性心筋梗塞診断の標準的治療法となっています。

検査の種類ポイントオブケア検査の採用増加

臨床検査は、通常病院や診断センター内の管理された検査室環境で患者検体を分析するもので、最高の精度を得るために高度な機器を使用します。心臓マーカー検査は感度と特異度が高いため、検査室環境において正確な結果が求められる場合に好ましい選択肢となります。Point-of-Care Testing（POCT）は、患者に近い場所で迅速な結果を提供し、緊急の心臓疾患状態において極めて重要であり、心臓疾患状態における患者の転帰に大きな影響を与えるリアルタイムで実用的な決定を容易にします。

疾患心筋梗塞における心臓マーカー検査の広範なアプリケーション

B型ナトリウム利尿ペプチド（BNP）およびN末端プロb型ナトリウム利尿ペプチド（NT-proBNP）検査は、症状を迅速かつ正確に検出できることから、うっ血性心不全の主要な心臓マーカー検査として使用されています。心筋梗塞の状態は、心筋損傷後に血中のトロポニンTおよびIレベルが上昇するため、トロポニン検査のような心臓マーカー検査によって効果的に分析されます。

地域別インサイト

南北アメリカ地域では、技術の進歩と心血管疾患の有病率の上昇に伴い、心臓マーカー検査市場が活況を呈しています。米国、カナダ、ブラジルなどの主要国では、複数の現地企業や新興企業が、効果的な心臓評価のための費用対効果の高いポータブル機器の開発・導入に注力しています。欧州地域では、心臓マーカー検査市場は、心血管疾患の増加、高齢化、確立されたヘルスケアインフラによって大きく牽引されています。中東・アフリカ地域の心臓マーカー検査市場は、冠動脈疾患に対する意識の高まりと医療サービスの拡大により大きな影響を受けています。心臓マーカー検査市場は、中国、インド、日本を含むAPAC諸国では、ヘルスケアサービスの急増と大手企業の大きな存在感により、加速度的に成長しています。ヘルスケア研究開発への投資という観点からの政府支援により、心臓検査法のイノベーションが増加しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは心臓マーカー検査市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、心臓マーカー検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.心臓マーカー検査市場の市場規模および予測は？

2.心臓マーカー検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.心臓マーカー検査市場の技術動向と規制枠組みは？

4.心臓マーカー検査市場における主要ベンダーの市場シェアは？

5.心臓マーカー検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の有病率と効果的な診断の必要性
    • 世界中で心臓マーカーのポイントオブケア検査が増加
    • 心血管疾患の早期発見とスクリーニングを促進する取り組み
  • 抑制要因
    • 心臓マーカー検査製品の有害リコール
  • 機会
    • 検査技術の進歩と新しいバイオマーカーの統合
    • 個別化医療への移行とテーラーメイド医療のイントロダクション
  • 課題
    • 心臓マーカー検査の不正確さと限定された特定性に関連する懸念
• 市場セグメンテーション分析
  • 製品：心臓マーカー検査における診断機器の重要性
  • バイオマーカー：心臓評価におけるトロポニンバイオマーカーの利用増加
  • 検査の種類：ポイントオブケア検査の採用の増加
  • 疾患：心筋梗塞における心臓マーカー検査の広範な応用
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 心臓マーカー検査市場：製品別

• 機器
• 試薬とキット

第7章 心臓マーカー検査市場バイオマーカー

• BNPまたはNT-ProBNP
• セラチンキナーゼ-MB
• hs-CRP
• ミオグロビン
• トロポニン

第8章 心臓マーカー検査市場テストの種類別

• 臨床検査
• ポイントオブケア検査

第9章 心臓マーカー検査市場：疾患別

• うっ血性心不全
• 心筋梗塞

第10章 南北アメリカの心臓マーカー検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の心臓マーカー検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの心臓マーカー検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • マインドレイ、新たなアッセイの発売により心臓バイオマーカーポートフォリオを拡大
  • NOWDxとAeenaDxが合併を発表
  • パスカインド・ラボとロシュ・ダイアグノスティクスが心臓バイオマーカーのリリースで提携
• 戦略分析と提言

第14章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CARDIAC MARKER TESTING MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC MARKER TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CARDIAC MARKER TESTING MARKET DYNAMICS
• FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 18. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 24. CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY ELISA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOCHROMATOGRAPHY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY BNP OR NT-PROBNP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CERATINE KINASE-MB, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY HS-CRP, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOGLOBIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY CONGESTIVE HEART FAILURE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 48. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 49. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 50. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 59. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 60. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 61. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 62. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 69. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 70. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 71. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 72. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 79. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 80. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 81. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 82. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 83. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 84. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 85. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 86. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 87. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 88. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 89. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 90. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 91. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 92. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 93. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 94. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 95. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 96. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 99. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 100. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 101. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 102. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 111. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 112. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 113. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 114. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 123. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 124. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 125. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 126. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 131. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 132. AUSTRALIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 133. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 134. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 135. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 136. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 137. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 138. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 139. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 140. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 141. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 142. CHINA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 143. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 144. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 145. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 146. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 147. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 148. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 149. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 150. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 151. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 152. INDIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 153. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 154. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 155. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 156. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 159. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 160. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 161. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 162. INDONESIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 163. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 164. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 165. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 166. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 167. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 168. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 169. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 170. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 171. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 172. JAPAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 173. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 174. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 175. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 176. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 177. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 178. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 179. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 180. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 181. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 182. MALAYSIA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 183. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 184. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 185. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 186. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 187. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 188. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 189. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 190. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 191. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 192. PHILIPPINES CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 193. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 194. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 195. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 196. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 197. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 198. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 199. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 200. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 201. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 202. SINGAPORE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 203. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 204. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 205. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 206. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 208. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 210. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 212. SOUTH KOREA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 213. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 214. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 215. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 216. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 217. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 218. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 219. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 220. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 221. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 222. TAIWAN CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 223. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 224. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 225. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 226. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 227. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 228. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 229. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 230. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 231. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 232. THAILAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 233. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 234. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 235. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 236. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 237. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 238. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 239. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 240. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 241. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 242. VIETNAM CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 255. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 256. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 257. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 258. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 259. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 260. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 261. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 262. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 263. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 264. DENMARK CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 265. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 266. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 267. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 268. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 269. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 270. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 271. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 272. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 273. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 274. EGYPT CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 275. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 276. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 277. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 278. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 279. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 280. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 281. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 282. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 283. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 284. FINLAND CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 285. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 286. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 287. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 288. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 289. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 290. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 291. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 292. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 293. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 294. FRANCE CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 295. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 296. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 297. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 298. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 299. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 300. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 301. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 302. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 303. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 304. GERMANY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 305. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 306. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 307. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 308. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 309. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 310. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 311. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 312. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 313. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 314. ISRAEL CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 315. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 316. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 317. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 318. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 319. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 320. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 321. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 322. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 323. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 324. ITALY CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 325. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 326. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 327. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 328. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 329. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 330. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 331. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 332. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 333. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
• TABLE 334. NETHERLANDS CARDIAC MARKER TESTING MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
• TABLE 335. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
• TABLE 336. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
• TABLE 337. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2023 (USD MILLION)
• TABLE 338. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2024-2030 (USD MILLION)
• TABLE 339. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2018-2023 (USD MILLION)
• TABLE 340. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY BIOMARKER, 2024-2030 (USD MILLION)
• TABLE 341. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2018-2023 (USD MILLION)
• TABLE 342. NIGERIA CARDIAC MARKER TESTING MARKET SIZE, BY TYPE OF TESTING, 2024-2030 (USD MILLION)
• TABLE 343. NIGE

[199 Pages Report] The Cardiac Marker Testing Market size was estimated at USD 5.10 billion in 2023 and expected to reach USD 5.50 billion in 2024, at a CAGR 7.90% to reach USD 8.69 billion by 2030.

Cardiac marker testing market consists of the spectrum of medical technologies and services that revolve around the usage of biomarkers for the diagnosis and management of cardiovascular diseases. The prevalence of cardiovascular diseases and need for effective diagnostics has increased the adoption of cardiac markers worldwide. The rise of point-of-care testing for cardiac markers has significantly increased the screening of cardiovascular diseases. The initiatives encouraging early cardiovascular disease detection have also contributed to market growth. However, the incidences of product recalls of cardiac marker testing solutions may limit its market adoption. The concerns associated with inaccuracy and limited specificity of cardiac market testing are also challenging factors for the market growth. Moreover, the advancements in testing technologies and the integration of new biomarkers are creating attractive opportunities in the market. Increasing consumer preference towards personalized medicine and the introduction of tailored cardiac marker testing are expected to witness significant growth in upcoming years.

Product: Significance of diagnostic instruments in cardiac marker testing

Diagnostic instruments in cardiac marker testing includes immunoassay analyzers, point of care (POC) devices, and chemiluminescence analyzers utilized to monitor and measure cardiac markers corresponding to heart conditions. Diagnostic instruments offer essential data evaluation for cardiac tests in a highly accurate, timely, and user-friendly manner. Reagents & kits are chemical solutions used for the proper functioning of instruments and the successful execution of cardiac marker testing procedures. Reagents & kits are vital in reacting with the biological samples, thereby helping to detect cardiac markers for various cardiac conditions.

Biomarker: Rising utilization of Troponin biomarker for cardiac assessment

Natriuretic peptides such as N-terminal proBNP (NT-proBNP) and B-type Natriuretic Peptide (BNP) are essential in the evaluation of heart failure, helping clinicians on cardiac disease management. Though CK-MB, a Creatine Kinase-MB isoenzyme, has been used in periprocedural myocardial infarction testings to better diagnose cardiac condition. High-sensitivity C-reactive protein (hs-CRP) testing is particularly advantageous for identifying low-grade inflammation to assess the risk of cardiovascular disease and stroke. Myoglobin is also a significant cardiac biomarker, favored for its very early peak (1 to 3 hours) following myocardial injury, primarily beneficial in the early detection of myocardial infarction. Troponin tests are currently the standard of care for diagnosing acute myocardial infarction due to their superior sensitivity and specificity.

Type of Testing: Increasing adoption of Point-of-Care testing

Laboratory testing involves analyzing patient samples in controlled lab environments, usually within hospitals or diagnostic centers, and utilizes advanced equipment for utmost accuracy. The high sensitivity and specificity of cardiac marker tests make it the preferred choice when precise results are mandatory in laboratory settings. Point-of-Care Testing (POCT) delivers rapid results in close proximity to the patient's location and are crucial in emergency cardiac conditions, facilitating real-time, actionable decisions that can significantly impact patient outcomes in cardiac disease conditions.

Disease: Extensive applications of cardiac marker testing in myocardial infarction

B-type Natriuretic Peptide (BNP) and N-terminal pro b-type Natriuretic Peptide (NT-proBNP) testing are used as primary cardiac marker tests for congestive heart failure due to their ability to prompt and accurate detection of symptoms. Myocardial infarction condition is effectively analyzed by cardiac marker tests such as troponin tests as troponin T and I levels in the blood increases after heart muscle damage.

Regional Insights

In the Americas region, the cardiac marker testing market has been flourishing with advancements in technology and the escalating prevalence of cardiovascular diseases. Several local companies and start-ups in major countries such as the United States, Canada, and Brazil, have been focusing on developing and introducing cost-effective and portable devices for effective cardiac assessment. In the Europe region, the cardiac marker testing market has been extensively driven by the increasing number of cardiovascular diseases, the aging population, and the well-established healthcare infrastructure. The cardiac marker testing market in the Middle East and Africa has been significantly impacted due to the rising awareness about coronary people diseases and the expansion of healthcare services. Cardiac marker testing market has been growing at an accelerated rate in APAC countries including China, India, and Japan due to the surge in healthcare services and the significant presence of major companies. The government support in terms of investments for healthcare research and development has led to an increase in innovations in cardiac testing methods.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Cardiac Marker Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cardiac Marker Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Marker Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Assure Tech (Hangzhou) Co., Ltd., Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Biomerieux SA, Boditech Med Inc., Charles River Laboratories International, Inc., Cleerly, Inc., Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche AG, HyTest Ltd., Laboratory Corporation of America Holdings, LightDeck Diagnostics, Merck KGaA, Natera, Inc., PerkinElmer Inc., Qiagen N.V., Quest Diagnostics, QuidelOrtho Corporation, Randox Laboratories Ltd., Sekbio, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Marker Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Product
  • Instruments
    • Chemiluminescence
    • ELISA
    • Immunochromatography
    • Immunofluorescence

• Reagents & Kits

• Biomarker
  • BNP Or NT-ProBNP
  • Ceratine Kinase-MB
  • hs-CRP
  • Myoglobin
  • Troponin

• Type of Testing
  • Laboratory Testing
  • Point-Of-Care Testing

• Disease
  • Congestive Heart Failure
  • Myocardial Infarction

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Cardiac Marker Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cardiac Marker Testing Market?

3. What are the technology trends and regulatory frameworks in the Cardiac Marker Testing Market?

4. What is the market share of the leading vendors in the Cardiac Marker Testing Market?

5. Which modes and strategic moves are suitable for entering the Cardiac Marker Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiovascular diseases and need for effective diagnostics
    • 5.1.1.2. Rise of point-of-care testing for cardiac markers worldwide
    • 5.1.1.3. Initiatives encouraging early detection and screening of cardiovascular diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of cardiac marker testing products
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in testing technologies and integration of new biomarkers
    • 5.1.3.2. Shift toward personalized medicine and introduction of tailored cardiac marker testing
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with inaccuracy and limited specificity of cardiac marker testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Significance of diagnostic instruments in cardiac marker testing
  • 5.2.2. Biomarker: Rising utilization of Troponin biomarker for cardiac assessment
  • 5.2.3. Type of Testing: Increasing adoption of Point-of-Care testing
  • 5.2.4. Disease: Extensive applications of cardiac marker testing in myocardial infarction
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Cardiac Marker Testing Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Kits

7. Cardiac Marker Testing Market, by Biomarker

• 7.1. Introduction
• 7.2. BNP Or NT-ProBNP
• 7.3. Ceratine Kinase-MB
• 7.4. hs-CRP
• 7.5. Myoglobin
• 7.6. Troponin

8. Cardiac Marker Testing Market, by Type of Testing

• 8.1. Introduction
• 8.2. Laboratory Testing
• 8.3. Point-Of-Care Testing

9. Cardiac Marker Testing Market, by Disease

• 9.1. Introduction
• 9.2. Congestive Heart Failure
• 9.3. Myocardial Infarction

10. Americas Cardiac Marker Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cardiac Marker Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cardiac Marker Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Mindray Expands Cardiac Biomarker Portfolio with Launch of New Assays
  • 13.3.2. NOWDx and AeenaDx Announce Merger
  • 13.3.3. Pathkind Labs, Roche Diagnostics Partner to Release Cardiac Biomarker
• 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

• 14.1. Key Company Profiles
• 14.2. Key Product Portfolio